NCT00611507View on ClinicalTrials.gov

A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

April 30, 2004

Conditions

Stomach Neoplasms

Interventions

DRUG

Oxaliplatin, 5-Fluorouracil

5FU 500 mg/m² per week in IV bolus infusion during 30 min AF 20mg/m²/week in infusion, during 10-20 minutes prior 5FU infusion; Eloxatin 85 mg/m² as IV infusion 2-6 hours, every 2 weeks. Three weeks of treatment, one week rest.

Trial Locations (1)

Unknown

Sanofi-Aventis, Bogotá